iRadimed Reports Q3 Revenue Beat and In-Line Non-GAAP EPS
iRadimed (NASDAQ: IRMD) reported third-quarter financial results featuring a revenue beat of $0.77 million, totaling $24.2 million. This represents a 14.2% increase year-over-year. The company's Non-GAAP earnings per share (EPS) of $0.55 met market expectations. Looking ahead to the fourth quarter of 2026, iRadimed issued revenue guidance in the range of $25.0 million to $26.5 million. This projection aligns closely with the consensus estimate of approximately $26.23 million, suggesting steady growth momentum for the medical technology provider.
Tickers: $IRMD